Stephen R Baldassarri1, Ansel T Hillmer2,3, Jon Mikael Anderson3, Peter Jatlow3,4, Nabeel Nabulsi2, David Labaree2, Kelly P Cosgrove2,3, Stephanie S O'Malley3, Thomas Eissenberg5, Suchitra Krishnan-Sarin3, Irina Esterlis3. 1. Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT. 2. PET center, Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT. 3. Department of Psychiatry, Yale School of Medicine, New Haven, CT. 4. Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT. 5. Department of Psychology (Health Program) and Center for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA.
Abstract
Background: Electronic cigarettes (ECs) can influence nicotine addiction by delivering aerosolized nicotine. We investigated if nicotine from ECs is delivered to the brain β2*-nicotinic acetylcholine receptors (β2*-nAChR) and how this relates to the behavioral effects and nicotine delivery from cigarettes. Methods: Seven nicotine users participated in positron emission tomography (PET) studies with (-)-[18F]Flubatine before and after nicotine challenge with 0, 8, and 36 mg/ml nicotine in a 3.3 Volt, 1.5 Ohm EC or a standard tobacco cigarette. Craving was evaluated before and after product use. Results: Average β2*-nAChR occupancy was higher after 36 mg/ml EC challenge compared to 8 mg/ml EC at trend level. Average β2*-nAChR occupancy after tobacco cigarette smoking was 68 ± 18% and was not different compared with 8 mg/ml (64 ± 17%,) or 36 mg/ml (84 ± 3%) nicotine in EC users. Area under the curve (AUC) of blood nicotine level was higher in the cigarette smoking group compared with the 8mg/ml group (p = 0.03), but similar compared with the 36 mg/ml EC (p = 0.29). Drug craving was reduced after use of the tobacco cigarette, 8 mg/ml EC, and 36 mg/ml EC. Conclusions: In this novel investigation of EC effects at β2*-nAChRs, we show that average β2*-nAChR occupancy was higher after 36 mg/ml EC challenge compared with 8 mg/ml EC. Receptor occupancy and arterial blood nicotine levels after cigarette smoking were similar to 36 mg/ml EC use under controlled conditions. These findings suggest that the ECs studied here have abuse liability and may provide an adequate alternative nicotine delivery system for cigarette smokers. Implications: This is the first study to directly determine the neurologic effects of electronic cigarettes on human brain beta-2 nicotinic acetylcholine receptors using PET neuroimaging with (-)-[18F]Flubatine, a novel radiotracer. Our findings suggest that the e-cigarettes studied here have abuse liability and may provide an adequate alternative nicotine delivery system for cigarette smokers.
Background: Electronic cigarettes (ECs) can influence nicotine addiction by delivering aerosolized nicotine. We investigated if nicotine from ECs is delivered to the brain β2*-nicotinic acetylcholine receptors (β2*-nAChR) and how this relates to the behavioral effects and nicotine delivery from cigarettes. Methods: Seven nicotine users participated in positron emission tomography (PET) studies with (-)-[18F]Flubatine before and after nicotine challenge with 0, 8, and 36 mg/ml nicotine in a 3.3 Volt, 1.5 Ohm EC or a standard tobacco cigarette. Craving was evaluated before and after product use. Results: Average β2*-nAChR occupancy was higher after 36 mg/ml EC challenge compared to 8 mg/ml EC at trend level. Average β2*-nAChR occupancy after tobacco cigarette smoking was 68 ± 18% and was not different compared with 8 mg/ml (64 ± 17%,) or 36 mg/ml (84 ± 3%) nicotine in EC users. Area under the curve (AUC) of blood nicotine level was higher in the cigarette smoking group compared with the 8mg/ml group (p = 0.03), but similar compared with the 36 mg/ml EC (p = 0.29). Drug craving was reduced after use of the tobacco cigarette, 8 mg/ml EC, and 36 mg/ml EC. Conclusions: In this novel investigation of EC effects at β2*-nAChRs, we show that average β2*-nAChR occupancy was higher after 36 mg/ml EC challenge compared with 8 mg/ml EC. Receptor occupancy and arterial blood nicotine levels after cigarette smoking were similar to 36 mg/ml EC use under controlled conditions. These findings suggest that the ECs studied here have abuse liability and may provide an adequate alternative nicotine delivery system for cigarette smokers. Implications: This is the first study to directly determine the neurologic effects of electronic cigarettes on human brain beta-2 nicotinic acetylcholine receptors using PET neuroimaging with (-)-[18F]Flubatine, a novel radiotracer. Our findings suggest that the e-cigarettes studied here have abuse liability and may provide an adequate alternative nicotine delivery system for cigarette smokers.
Authors: Vincent J Cunningham; Eugenii A Rabiner; Mark Slifstein; Marc Laruelle; Roger N Gunn Journal: J Cereb Blood Flow Metab Date: 2009-09-09 Impact factor: 6.200
Authors: Alexa A Lopez; Marzena M Hiler; Eric K Soule; Carolina P Ramôa; Nareg V Karaoghlanian; Thokozeni Lipato; Alison B Breland; Alan L Shihadeh; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2015-09-16 Impact factor: 4.244
Authors: Theodore L Wagener; Evan L Floyd; Irina Stepanov; Leslie M Driskill; Summer G Frank; Ellen Meier; Eleanor L Leavens; Alayna P Tackett; Neil Molina; Lurdes Queimado Journal: Tob Control Date: 2016-10-11 Impact factor: 7.552
Authors: Carolina P Ramôa; Marzena M Hiler; Tory R Spindle; Alexa A Lopez; Nareg Karaoghlanian; Thokozeni Lipato; Alison B Breland; Alan Shihadeh; Thomas Eissenberg Journal: Tob Control Date: 2015-08-31 Impact factor: 7.552
Authors: Arthur L Brody; Mark A Mandelkern; Matthew R Costello; Anna L Abrams; David Scheibal; Judah Farahi; Edythe D London; Richard E Olmstead; Jed E Rose; Alexey G Mukhin Journal: Int J Neuropsychopharmacol Date: 2008-08-18 Impact factor: 5.176
Authors: Alison Breland; Robert L Balster; Caroline Cobb; Pebbles Fagan; Jonathan Foulds; J Randy Koch; Thokozeni Lipato; Najat Saliba; Alan Shihadeh; Shumei Sun; Thomas Eissenberg Journal: Am Psychol Date: 2019-04
Authors: Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare Journal: J Neuroimmune Pharmacol Date: 2019-12-13 Impact factor: 4.147
Authors: Kelly Smart; Mika Naganawa; Stephen R Baldassarri; Nabeel Nabulsi; Jim Ropchan; Soheila Najafzadeh; Hong Gao; Antonio Navarro; Vanessa Barth; Irina Esterlis; Kelly P Cosgrove; Yiyun Huang; Richard E Carson; Ansel T Hillmer Journal: Cereb Cortex Date: 2021-05-10 Impact factor: 5.357